found that anti-TNFα treatment already induced a rapid decrease in sCD163 levels one day after treatment initiation followed by a further decrease at week 1 and week 6, while in patients treated with prednisolone, sCD163 decline failed to reach statistical significance; however, no association was observed with clinical response [ 11 ].
← all excerpts
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases.
1
—
—